Impact of the coronavirus disease 2019 pandemic on acute cardiac care units: A French nationwide observational database study comparing 2020 and 2022
This study underscores the resilience of intensive cardiac care unit care in France throughout the COVID-19 pandemic, and emphasizes the need for continuous evaluations of resource allocation and care strategies aimed at high-risk populations.
Authors
- François Roubille (ORCID: https://orcid.org/0000-0002-5288-9687)
- Grégoire Mercier (ORCID: https://orcid.org/0000-0001-5531-4515)
- Clément Delmas (ORCID: https://orcid.org/0000-0001-9180-9128)
- Hugo Guillermou
- Eric Bonnefoy‐Cudraz
Institutions
- Centre National de la Recherche Scientifique (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Université de Montpellier (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Toulouse Mathematics Institute (FR)
- Hospices Civils de Lyon (FR)
Publication Details
- Journal
- Archives of cardiovascular diseases
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1016/j.acvd.2025.04.054
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Pfizer
- AstraZeneca
- Sanofi
- Alnylam Pharmaceuticals
- Vifor Pharma
- Servier